American Century Companies’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-19,025
Closed -$1.11M 2016
2020
Q3
$1.11M Buy
19,025
+233
+1% +$17.3K ﹤0.01% 1105
2020
Q2
$2.1M Sell
18,792
-35
-0.2% -$2.49K ﹤0.01% 902
2020
Q1
$1.27M Sell
18,827
-4,298
-19% -$433K ﹤0.01% 940
2019
Q4
$3.2M Sell
23,125
-3,295
-12% -$427K ﹤0.01% 865
2019
Q3
$2.77M Buy
26,420
+6,204
+31% +$619K ﹤0.01% 921
2019
Q2
$2.15M Buy
20,216
+4,108
+26% +$541K ﹤0.01% 1015
2019
Q1
$2.49M Sell
16,108
-66
-0.4% -$7.65K ﹤0.01% 965
2018
Q4
$1.5M Buy
16,174
+2,589
+19% +$370K ﹤0.01% 1013
2018
Q3
$2.53M Buy
13,585
+3,066
+29% +$874K ﹤0.01% 994
2018
Q2
$4.42M Buy
10,519
+3,337
+46% +$1.12M ﹤0.01% 874
2018
Q1
$2.16M Buy
7,182
+1,028
+17% +$285K ﹤0.01% 987
2017
Q4
$1.75M Buy
+6,154
New +$1.73M ﹤0.01% 1026

Other funds holding OPTN

American Century Companies's OPTN Position: Q4 2020 in Review

American Century Companies sold out of OptiNose (OPTN) in Q4 2020, closing a stake of 19,025 shares — an estimated $1.11M sold.

American Century Companies first reported a position in OPTN in Q4 2017 and held it in 12 quarters. The position peaked at $4.42M in Q2 2018. 67 funds tracked by Wall St. Rank hold OPTN as of Q4 2020.

  • American Century Companies reported no remaining OptiNose position as of Q4 2020 after selling out during the quarter.
  • American Century Companies sold 19,025 OptiNose shares in Q4 2020, an estimated $1.11M.
  • American Century Companies first reported a position in OptiNose in Q4 2017 and held it in 12 quarters.
  • American Century Companies's OptiNose position peaked at $4.42M in Q2 2018.
  • 67 funds tracked by Wall St. Rank held OptiNose as of Q4 2020.

Based on American Century Companies's 13F filing for Q4 2020, filed 12 Feb 2021.